Benefits and limitations of randomized controlled trials: A commentary on Deaton and Cartwright

被引：10
|
作者：
Gelman, Andrew [1 ,2 ]
机构：
[1] Columbia Univ, Dept Stat, New York, NY 10027 USA
[2] Columbia Univ, Dept Polit Sci, New York, NY 10027 USA
来源：
SOCIAL SCIENCE & MEDICINE | 2018年 / 210卷
关键词：
D O I：
10.1016/j.socscimed.2018.04.034
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：48 / 49
页数：2
相关论文
共 50 条
  • [21] Overestimation of the Limitations of Randomized Controlled Trials
    Bergman, Jonathan
    Nordstrom, Anna
    Nordstrom, Peter
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 (09) : 1767 - 1768
  • [22] The limitations of randomized controlled trials in predicting effectiveness
    Cartwright, Nancy
    Munro, Eileen
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2010, 16 (02) : 260 - 266
  • [23] Ethical and Empirical Limitations of Randomized Controlled Trials
    Porzsolt, Franz
    Kliemt, Hartmut
    MEDIZINISCHE KLINIK, 2008, 103 (12) : 836 - 842
  • [24] The potential role for sociologists in designing RCTs and of RCTs in refining sociological theory: A commentary on Deaton and Cartwright
    Bonell, Chris
    Melendez-Torres, G. J.
    Quilley, Stephen
    SOCIAL SCIENCE & MEDICINE, 2018, 210 : 29 - 31
  • [25] MEASURING COSTS AND FINANCIAL BENEFITS IN RANDOMIZED CONTROLLED TRIALS
    BULPITT, CJ
    FLETCHER, AE
    AMERICAN HEART JOURNAL, 1990, 119 (03) : 766 - 771
  • [26] Asymmetric Reporting of Harms and Benefits in Randomized Controlled Trials
    Yeahia, Rubaya
    Gennarelli, Renee L.
    Morgan, Daniel J.
    Korenstein, Deborah
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2022, 37 (08) : 2113 - 2115
  • [27] Asymmetric Reporting of Harms and Benefits in Randomized Controlled Trials
    Rubaya Yeahia
    Renee L. Gennarelli
    Daniel J. Morgan
    Deborah Korenstein
    Journal of General Internal Medicine, 2022, 37 : 2113 - 2115
  • [28] Randomized concentration-controlled trials: Motivations, use, and limitations
    Kraiczi, H
    Jang, T
    Ludden, T
    Peck, CC
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (03) : 203 - 214
  • [29] Poorly Recognized and Uncommonly Acknowledged Limitations of Randomized Controlled Trials
    Andrade, Chittaranjan
    INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE, 2025, 47 (01) : 83 - 85
  • [30] Use of Placebo in Urologic Oncology Randomized Controlled Trials Commentary
    Jones, J. Stephen
    UROLOGY PRACTICE, 2024, 11 (06) : 948 - 948
12345